Halozyme names new head of IR

Nov 07, 2018
Biotech firm appoints Albert Kildani as vice president of IR and corporate communications
San Diego-headquartered biotech firm Halozyme, which develops oncology and drug-delivery therapies, has named Albert Kildani as its new vice president of IR and corporate communications. As well as serving as the primary contact for analysts and the investment

Content Preview

to continue reading

  • Unlimited news online
  • Newsletter
Sign up to get stories direct to your inbox
logo-black logo-black